Connect Share Price
NASDAQ: CNTB | Micro Cap | HealthcareConnect Stock Performance
Connect Share Price Today
As of 19 November 2026, Connect Biopharma Holdings Limited's share price is $0.66. The stock opened at $0.57, compared to its previous close of $0.57. During today's trading session, Connect Biopharma Holdings Limited's share price traded between $0.57 and $0.64, with an average price of $0.60. Over the past 52 weeks, the stock has recorded a high of $3.74 and a low of $0.55. In terms of performance, Connect Biopharma Holdings Limited's share price has declined by 73.46% over the last six months and is down 76.15% on a year-on-year basis.
Connect Share Price Chart
Connect Quarterly Profit & Loss
All figures in USD
Connect Annual Profit & Loss
All figures in USD
Connect Balance Sheet
All figures in USD Million
Connect Cash Flow
All figures in USD Million
About Connect
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
Connect Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.80 | $0.62 | -22.29% |
Oct 2026 | $1.11 | $0.79 | -27.49% |
Sep 2026 | $2.19 | $1.09 | -51.97% |
Aug 2026 | $2.06 | $2.28 | +12.87% |
Jul 2026 | $2.39 | $2.02 | -14.95% |
Jun 2026 | $2.49 | $2.38 | -4.23% |
May 2026 | $2.46 | $2.48 | +1.22% |
Apr 2026 | $2.69 | $2.45 | -5.77% |
Mar 2026 | $2.50 | $2.60 | +4.00% |
Feb 2026 | $2.44 | $2.50 | +2.67% |
Jan 2026 | $2.68 | $2.44 | -13.04% |
Dec 2025 | $2.77 | $2.80 | +1.45% |